Aranesp 25 mcg (Darbepoetin Alfa SOLUTION) 25 MCG

ARANESP 25 MCG is a solution containing darbepoetin alfa, used to manage anemia in certain conditions. This intravenous medication supports red blood cell production, often in chronic kidney disease or chemotherapy.

Strength

25 MCG

Manufacturer / TM Owner

AMGEN CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ARANESP 25 MCG is primarily used to treat anemia associated with chronic kidney disease and chemotherapy. Darbepoetin alfa works by stimulating the bone marrow to produce more red blood cells, which can help alleviate symptoms of anemia such as fatigue and weakness. It is administered intravenously and is often prescribed when the body's natural production of red blood cells is insufficient.

Side Effects

Common effects of ARANESP 25 MCG may include increased red blood cell production, which can improve energy levels and reduce fatigue. Some individuals may experience mild injection site reactions or flu-like symptoms. It is important to monitor blood pressure and other vital signs regularly while using this medication.

Precautions & Warnings

ARANESP 25 MCG should be used under medical supervision. It is important to inform your healthcare provider about any existing medical conditions or allergies. Regular blood tests may be required to monitor the effectiveness and safety of the treatment. This medication should be stored as per the manufacturer's instructions to maintain its potency.

Avoid Interactions

ARANESP 25 MCG may interact with other medications, including certain iron supplements and other drugs that affect red blood cell production. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the effectiveness of this medication.

Frequently Asked Questions

ARANESP 25 MCG is used to treat anemia in individuals with chronic kidney disease or those undergoing chemotherapy.

ARANESP 25 MCG is administered intravenously, typically by a healthcare professional.

Common side effects may include injection site reactions, flu-like symptoms, and changes in blood pressure.

It is important to consult a healthcare provider before using ARANESP 25 MCG with other medications to avoid potential interactions.

ARANESP 25 MCG should be stored according to the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.